US eyes 100% tariffs on foreign drugs…

Foreign-made drugs could soon face 100% US import tariffs, but that figure is likely an opening bid in negotiations — and there are still compelling ways to invest in healthcare, Impax Asset Management’s Nathan Moser says

Read More